[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Schmitz F., Scherer E.B.S., Machado F.R., da Cunha A.A., Tagliari B., Netto C.A., Wyse A.T.S
Stanbury shared that she stopped using the injections after she lost the weight, but confirmed she would happily take Ozempic again if she felt she needed to
Rising HbA1c levels, persistently elevated blood glucose readings, or return of hyperglycaemic symptoms may indicate inadequate glycaemic control requiring medical review
(31) The time at which someone starts a treatment for obesity can itself be correlated with mental health difficulties, and the effects of the medication on weight, whether this is a dramatic reduction in weight, or a disappointing lack of weight reduction, can also trigger changes in mental health. (32) Based on major long-term trials, including FLOW (chronic kidney disease), SELECT (obesity/cardiovascular disease without diabetes), and SUSTAIN-6 (type 2 diabetes), semaglutide has demonstrated significant benefits across the cardiovascular and renal systems
